Edition:
United Kingdom

Natus Medical Inc (BABY.OQ)

BABY.OQ on NASDAQ Stock Exchange Global Select Market

34.25USD
19 Sep 2018
Change (% chg)

$-0.55 (-1.58%)
Prev Close
$34.80
Open
$34.75
Day's High
$35.00
Day's Low
$33.85
Volume
65,147
Avg. Vol
61,743
52-wk High
$43.55
52-wk Low
$28.05

Latest Key Developments (Source: Significant Developments)

Natus Appoints Drew Davies Executive Vice-President And CFO
Monday, 17 Sep 2018 

Sept 17 (Reuters) - Natus Medical Inc ::NATUS APPOINTS DREW DAVIES EXECUTIVE VICE-PRESIDENT AND CFO.NATUS MEDICAL INC - SHARON VILLAVERDE, WHO HAS SERVED AS INTERIM CFO SINCE JULY 11, 2018, WILL CONTINUE IN HER ROLE AS VICE PRESIDENT OF FINANCE.NATUS MEDICAL - APPOINTMENT OF DREW DAVIES AS EXECUTIVE VICE-PRESIDENT AND CFO, EFFECTIVE OCTOBER 1, 2018.  Full Article

Natus Medical Q2 GAAP Loss Per Share $0.08
Wednesday, 25 Jul 2018 

July 25 (Reuters) - Natus Medical Inc ::NATUS MEDICAL INC ANNOUNCES SECOND QUARTER FINANCIAL RESULTS.Q2 NON-GAAP EARNINGS PER SHARE $0.35.Q2 GAAP LOSS PER SHARE $0.08.Q2 REVENUE $130.7 MILLION VERSUS I/B/E/S VIEW $130.5 MILLION.Q2 EARNINGS PER SHARE VIEW $0.26 -- THOMSON REUTERS I/B/E/S.SEES FY 2018 NON-GAAP EARNINGS PER SHARE $1.50 TO $1.60.SEES FY 2018 REVENUE $525 MILLION TO $535 MILLION.INC - FOR Q3 OF 2018, COMPANY PROVIDED REVENUE GUIDANCE TO $131.0 MILLION TO $135.0 MILLION.INC SEES Q3 NON-GAAP EARNINGS PER SHARE OF $0.40 TO $0.44.  Full Article

Jonathan Kennedy To Get $650,000 In 2018 As CEO Of Natus Medical
Thursday, 12 Jul 2018 

July 12 (Reuters) - Natus Medical Inc ::NATUS MEDICAL - JONATHAN KENNEDY WILL RECEIVE AN ANNUAL BASE SALARY OF $650,000 IN 2018, IN CONNECTION WITH HIS APPOINTMENT AS PRESIDENT AND CEO.  Full Article

Nox Medical Claims For Infringement By Natus Neurology
Monday, 21 May 2018 

May 21 (Reuters) - Nox Medical: :NOX MEDICAL SAYS CLAIMS FOR INFRINGEMENT BY NATUS NEUROLOGY.NOX MEDICAL - ALLEGES NATUS NEUROLOGY INFRINGED NOX MEDICAL'S PATENT COVERING BIOMETRIC CONNECTOR ON DISPOSABLE RIP BELTS.NOX MEDICAL SAYS JURY AWARDED CO DAMAGES FOR NATUS' INFRINGEMENT, AND FINDING THAT NATUS' INFRINGEMENT OF '532 PATENT WAS WILLFUL.  Full Article

Natus Medical Announces 2018 Annual And First Quarter Financial Guidance
Monday, 8 Jan 2018 

Jan 8 (Reuters) - Natus Medical ::REVENUE IN Q4 WAS LOWER THAN EXPECTED DUE TO WEAKNESS IN OUR U.S. NEURODIAGNOSTIC BUSINESS.‍FULL YEAR AND Q1 2018 NON-GAAP GUIDANCE DOES NOT INCLUDE EXPENSES FOR U.S. MEDICAL DEVICE TAX​.DUE IN PART TO DISRUPTION FROM INTEGRATION OF COMPUTER SYSTEMS, Q4 REVENUE ALSO LOWER THAN EXPECTED AT OTOMETRICS.‍IF NOT REPEALED OR SUSPENDED, MEDICAL DEVICE TAX WILL HAVE AN ANNUAL AFTER TAX COST OF APPROXIMATELY $3.0 MILLION​.INCREASING INVESTMENTS IN KEY PRODUCT AREAS IN 2018.ANNOUNCES 2018 ANNUAL AND FIRST QUARTER FINANCIAL GUIDANCE.SEES FY 2018 NON-GAAP EARNINGS PER SHARE $1.60 TO $1.65.SEES Q1 2018 REVENUE $125 MILLION TO $127 MILLION.SEES FY 2017 REVENUE $500.5 MILLION TO $501.5 MILLION.SEES FY 2018 REVENUE $535 MILLION TO $540 MILLION.SEES Q1 2018 NON-GAAP EARNINGS PER SHARE $0.23 TO $0.24.SEES Q4 2017 REVENUE ABOUT $131 MILLION TO $132 MILLION.EXPECT OTOSCAN REVENUES TO RAMP IN SECOND HALF OF 2018.  Full Article

Natus Medical Inc reports ‍Q3 loss per share of $0.26​
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - Natus Medical Inc :Natus Medical Inc - ‍Q3 2017 loss per share $0.26​.Sees FY 2017 non-GAAP earnings per share $1.72 to $1.76.Natus Medical Inc qtrly ‍adj earnings per share $0.40​.Sees Q4 2017 non-GAAP earnings per share $0.68 to $0.72.Natus Medical Inc - ‍for Q3, company reported revenue of $122.6 million, an increase of 34.9% compared to $90.9 million reported for Q3 2016​.Sees FY 2017 revenue $514.5 million to $516.5 million.Sees Q4 2017 revenue $145 million to $147 million.Q3 earnings per share view $0.38, revenue view $122.1 million -- Thomson Reuters I/B/E/S.FY2017 earnings per share view $1.70, revenue view $508.7 million -- Thomson Reuters I/B/E/S.Q4 earnings per share view $0.69, revenue view $136.5 million -- Thomson Reuters I/B/E/S.  Full Article

CORRECTED-Hedge fund Voce's nominees elected to Natus board

June 22 Natus Medical Inc said on Friday its stockholders had elected hedge fund Voce Capital Management's nominees to the company's board, ending a months long proxy fight.